Iuhw Narita Hospital

Narita 286-8520

2 studies enrolling now · 4 studies all time

What they study most

AChR-Ab Seropositive Generalized Myasthenia Gravis, Follicular Lymphoma, Generalized Myasthenia Gravis, Generalized Myasthenia Gravis (gMG), MG, Marginal Zone Lymphoma, Myasthenia Gravis, Myasthenia Gravis, Ocular, gMG

Studies at this site

• ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod — Recruiting now
• ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis — Recruiting now
• A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis — Running, not enrolling
• A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. — Running, not enrolling